致心律失常性右室心肌病室性心律失常新预测模型
采用Cox回归建立并内部验证了年度室性心律失常风险预测模型,优化校正C指数为0.77,临床获益优于现行基于共识的ICD植入算法。
要点
- 模型基于年龄、性别、晕厥、NSVT、PVC负荷、T波倒置导联数及右室射血分数等易得参数。
- 模型区分度良好,优化校正C指数0.77,校准斜率0.93。
- 决策曲线分析显示模型较共识ICD算法可减少20.6%的ICD植入且保护患者比例相同(P<0.001)。
核心结论
- 利用易得临床参数建立的预测模型可估算ARVC患者年度室性心律失常风险,并指导一级预防ICD决策。
研究设计与样本
- 随访4.83年(四分位距2.44-9.33年),采用Cox回归开发预测模型并进行内部验证。
主要发现
- 随访期间146例(27.7%)发生持续性室性心律失常,定义为心脏性猝死、流产的心脏性猝死、持续性室性心动过速或适当的ICD治疗。
- 最终模型保留年龄、性别、近6个月内心脏性晕厥、非持续性室性心动过速、24小时室性早搏数量、T波倒置导联数及右室射血分数,左室射血分数未保留。
- 模型优化校正C指数为0.77(95%CI 0.73-0.81),校准斜率为0.93(95%CI 0.92-0.95)。
- 决策曲线分析显示,模型临床获益优于现行基于共识的ICD植入算法,在保护患者比例相同的情况下减少20.6%的ICD植入(P<0.001)。
临床怎么用
- 该模型可用于ARVC患者个体化估算年度室性心律失常风险,辅助一级预防ICD植入决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC) is characterized by ventricular arrhythmias (VAs) and sudden cardiac death (SCD). We aimed to develop a model for individualized prediction of incident VA/SCD in ARVC patients. METHODS AND RESULTS: Five hundred and twenty-eight patients with a definite diagnosis and no history of sustained VAs/SCD at baseline, aged 38.2 ± 15.5 years, 44.7% male, were enrolled from five registries in North America and Europe. Over 4.83 (interquartile range 2.44-9.33) years of follow-up, 146 (27.7%) experienced sustained VA, defined as SCD, aborted SCD, sustained ventricular tachycardia, or appropriate implantable cardioverter-defibrillator (ICD) therapy. A prediction model estimating annual VA risk was developed using Cox regression with internal validation. Eight potential predictors were pre-specified: age, sex, cardiac syncope in the prior 6 months, non-sustained ventricular tachycardia, number of premature ventricular complexes in 24 h, number of leads with T-wave inversion, and right and left ventricular ejection fractions (LVEFs). All except LVEF were retained in the final model. The model accurately distinguished patients with and without events, with an optimism-corrected C-index of 0.77 [95% confidence interval (CI) 0.73-0.81] and minimal over-optimism [calibration slope of 0.93 (95% CI 0.92-0.95)]. By decision curve analysis, the clinical benefit of the model was superior to a current consensus-based ICD placement algorithm with a 20.6% reduction of ICD placements with the same proportion of protected patients (P < 0.001). CONCLUSION: Using the largest cohort of patients with ARVC and no prior VA, a prediction model using readily available clinical parameters was devised to estimate VA risk and guide decisions regarding primary prevention ICDs (www.arvcrisk.com).
引用
- Cadrin-Tourigny J, Bosman LP, Nozza A, et al. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2019. PMID: 30915475. doi:10.1093/eurheartj/ehz103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。